CBD Cholesterol Pill Shows Safety and Effectiveness in Israeli Trial
Israeli biotech CannaLean's CLC-01, a CBD-chitosan therapy for high LDL cholesterol, achieved a 28% reduction in a 12-week trial, showing safety and.
CLC-01
Navigation
Israeli biotech CannaLean's CLC-01, a CBD-chitosan therapy for high LDL cholesterol, achieved a 28% reduction in a 12-week trial, showing safety and.